Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis

• Published in: Antimicrobial Agents and Chemotherapy 2011-12, Vol.55 (12), p.5798-5803
• Main Authors: COMELY, O. A, VEHRESCHILD, J. J, HARNISCHMACHER, U, WILKENS, A, FAROWSKI, F, KARTHAUS, M, LEHRNBECHER, T, ULLMANN, A. J, HALLEK, M, GROLL, A. H, VEHRESCHILD, M. J. G. T, WÜRTHWEIN, G, ARENZ, D, SCHWARTZ, S, HEUSSEL, C. P, SILLING, G, MAHNE, M, FRANKLIN, J
• Format: Article
• Language: English
• Subjects: Antibiotics. Antiinfectious agents. Antiparasitic agents; Antifungal Agents; Antifungal Agents - administration & dosage; Antifungal Agents - adverse effects; Antifungal Agents - pharmacokinetics; Antifungal Agents - therapeutic use; Aspergillosis; Aspergillosis - drug therapy; Aspergillosis - microbiology; Aspergillosis - mortality; Biological and medical sciences; Clinical Therapeutics; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Echinocandins; Echinocandins - administration & dosage; Echinocandins - adverse effects; Echinocandins - pharmacokinetics; Female; Follow-Up Studies; Human mycoses; Humans; Infectious diseases; Lipopeptides; Male; Medical sciences; Middle Aged; Miscellaneous mycoses; Mycoses; Pharmacology. Drug treatments; Survival Analysis; Treatment Outcome
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/aac.05134-11

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • [e-mail] Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC